
News|Articles|December 1, 2007
First-time generic approvals, December 2007
First-time generic approvals: rivastigmine capsules
Advertisement
Key Points
Rivastigmine capsules, 1.5, 3, 4.5, and 6 mg base (equiv to Exelon capsules)
SUN
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Neffy’s first year: $72.2m in sales, 10,000 schools and broadening payer access
2
Brukinsa/rituximab cuts progression risk 43% in mantle cell lymphoma
3
A conversation about vaccines and monoclonal antibodies with Marc Elia, Chairman of Invivyd’s Board of Directors
4
New study confirms benefits of GLP-1 drugs in patients with PAD
5
































